论文部分内容阅读
为了解干扰素(IFN)治疗C型慢性肝炎的病理状态,进行如下研究.通过C100-3抗体(Chiron,EIA)或第二代HCV相关抗体(Dainabot,PHA)检查阳性、肝活检诊断为C型慢性肝炎的64例患者,在120～24WK内,每周3次应用IFN-α,其中27例应用后6个月后再次进行了肝脏活检,根据厚生省难治性肝炎研究班的标准判定疗效,把显效、有效者做为有效病例.结果32例有效病例(SR)中,17例
To investigate the pathophysiological status of interferon (IFN) in the treatment of chronic hepatitis C, the following studies were performed: positive by C100-3 antibody (Chiron, EIA) or second generation HCV-associated antibody (Dainabot, PHA) Sixty-four patients with chronic hepatitis B were treated with IFN-α three times a week at 120 to 24 WK, of which 27 patients were re-examined for liver biopsy 6 months after their application, and the efficacy was evaluated according to the criteria of the research group of the Ministry of Health, Welfare and Refractory Hepatitis , The effective and effective as valid cases.Results 32 cases of effective cases (SR), 17 cases